DSCM
RCEL icon

Divisadero Street Capital Management’s Avita Medical RCEL Stock Holding History

Divisadero Street Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Hold
100,000
– – 0.01% 132
2026
Q1 		$370K Hold
100,000
– – 0.02% 105
2025
Q4 		$345K Hold
100,000
– – 0.02% 86
2025
Q3 		$511K Buy
+100,000
New +$522K 0.02% 142

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Divisadero Street Capital Management's RCEL Position: Q2 2026 in Review

Divisadero Street Capital Management held its Avita Medical (RCEL) position steady in Q2 2026 at 100,000 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #132.

Divisadero Street Capital Management first reported a position in RCEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $511K in Q3 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Divisadero Street Capital Management held 100,000 shares of Avita Medical worth $413K as of Q2 2026.
  • Divisadero Street Capital Management left its Avita Medical share count unchanged in Q2 2026.
  • Avita Medical made up 0.01% of Divisadero Street Capital Management's portfolio in Q2 2026, its #132 holding.
  • Divisadero Street Capital Management first reported a position in Avita Medical in Q3 2025 and has held it in 4 quarters since.
  • Divisadero Street Capital Management's Avita Medical position peaked at $511K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.